platinum resistant ovarian cancer treatment

Ads
related to: platinum resistant ovarian cancer treatment
HCPs: Explore Resources - Explore The Benefits

www.hcp-ovarian-cancer-treatment.com
HCPs: Download Prescribing Info For An Advanced Ovarian Cancer Treatment Option. Review Data For An Advanced Ovarian Cancer Treatment Option To Discuss With Patients.
Important Safety Info · HCP Resource Library · Clinical Trial Data · HCP Resources & Materials
Ovarian Cancer Overview
Access Information On An Ovarian

Cancer Treatment Option.

Ovarian Cancer Info
Learn More About Ovarian Cancer

& What It Means For Your Patients.

Ovarian Cancer Treatment
Explore An Ovarian Cancer Treatment

Option & Speak With Your Patients.

Patient Information
Access Patient Info Regarding An

Ovarian Cancer Treatment Option.

Dosing And Administration
Explore Dosing Options For An

Ovarian Cancer Treatment.

View Supporting Resources
View Important Eligibility Info For

An Ovarian Cancer Treatment.
Ovarian Cancer Treatment - A Maintenance Therapy Option

www.treatmentforovariancancer.com
Learn About A Potential Treatment Option For Certain Patients With Ovarian Cancer. Find More Information To Help Inform Your Treatment Plan At The Official Patient Site.
Side Effect Information
Oral Medication
Genomic Testing
Clinical Study Data

Search results

- ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
  Zacks via Yahoo Finance· 2 years ago
  ImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead...
- Sonnet (SONN) Up as Ovarian Cancer Drug Enters Clinical Study
  Zacks via Yahoo Finance· 9 months ago
  Sonnet (SONN) receives FDA clearance to begin clinical development for its combination therapy of...
- ImmunoGen's Newly Approved Ovarian Cancer Drug Listed As Preferred Regime
  Benzinga via Yahoo Finance· 1 year ago
  The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer...
- ImmunoGen (IMGN) Gets Accelerated FDA Approval for Ovarian Cancer Drug
  Zacks via Yahoo Finance· 2 years ago
  ImmunoGen (IMGN) receives accelerated FDA approval for its lead drug mirvetuximab soravtansine-gynx,...
- Clovis (CLVS) Seeks Nod for Rubraca in First Line Ovarian Cancer
  Zacks via Yahoo Finance· 2 years ago
  Clovis (CLVS) files regulatory applications in the United States and Europe seeking label expansion...
- Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
  Zacks via Yahoo Finance· 1 month ago
  Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of...
- After FDA Approval For Ovarian Cancer Drug, ImmunoGen Becomes Top Pick For This Analyst
  Benzinga via Yahoo Finance· 2 years ago
  Tuesday, the FDA granted accelerated approval for ImmunoGen Inc's (NASDAQ: IMGN) Elahere...
- Myriad Genetics (MYGN) Adds New Test to Oncology Portfolio
  Zacks via Yahoo Finance· 12 months ago
  Myriad Genetics MYGN recently announced the addition of Folate Receptor Alpha (FRα) to its Precise...
- Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
  Zacks via Yahoo Finance· 6 months ago
  This week, AbbVie ABBV announced a definitive agreement to acquire cancer biotech Immunogen at a...
- Why Novocure Stock Fell 24.4% This Week
  Motley Fool· 9 months ago
  What happened Shares of Novocure (NASDAQ: NVCR) are down 25.9% so far this week as of the market close on Thursday, according to data provided by S&P...